32 phenotypes from 2 alleles in 3 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Plaaem1Pmi/Plaaem1Pmi C57BL/6J-Plaaem1Pmi	abnormal gait	J:240526
	abnormal miniature endplate potential	J:240526
	abnormal neuromuscular synapse morphology	J:240526
	abnormal PNS synaptic transmission	J:240526
	abnormal Purkinje cell dendrite morphology	J:240526
	abnormal Purkinje cell migration	J:240526
	abnormal Purkinje cell morphology	J:240526
	ataxia	J:240526
	decreased body weight	J:240526
	decreased brain size	J:240526
	decreased corpus callosum size	J:240526
	decreased grip strength	J:240526
	decreased locomotor activity	J:240526
	decreased miniature inhibitory postsynaptic current amplitude	J:240526
	decreased skeletal muscle fiber diameter	J:240526
	decreased survivor rate	J:240526
	gliosis	J:240526
	impaired balance	J:240526
	kyphosis	J:240526
	normal mortality/aging	J:240526
	paraparesis	J:240526
	skeletal muscle fiber atrophy	J:240526
	skeletal muscle necrosis	J:240526
	small cerebellum	J:240526
	tremors	J:240526
	weakness	J:240526
Plaaem1Pmi/Plaatm1(NCOM)Cmhd either: (involves: C57BL/6J * C57BL/6NTac) or (involves: C57BL/6J * C57BL/6NTac * CD-1)	abnormal gait	J:240526
	abnormal neuromuscular synapse morphology	J:240526
	decreased body weight	J:240526
	decreased locomotor activity	J:240526
	impaired balance	J:240526
	limb grasping	J:240526
	paralysis	J:240526
	preweaning lethality, complete penetrance	J:240526
	respiratory distress	J:240526
	small cerebellum	J:240526
	tremors	J:240526
	weakness	J:240526
Plaatm1(NCOM)Cmhd/Plaatm1(NCOM)Cmhd either: (involves: C57BL/6J * C57BL/6NTac) or (involves: C57BL/6NTac * CD1)	abnormal vesicle-mediated transport	J:240526
	prenatal lethality, complete penetrance	J:240526